First Header Logo Second Header Logo

Connection

Steven Feldman to Betamethasone

This is a "connection" page, showing publications Steven Feldman has written about Betamethasone.
Connection Strength

3.413
  1. Haidari W, Pona A, Feldman SR. Management of Residual Psoriasis in Patients on Biologic Treatment J Drugs Dermatol. 2020 Feb 02; 19(2):188-194.
    View in: PubMed
    Score: 0.678
  2. Feldman SR, Levi E, Pathak P, Kakatkar S, Balkrishnan R. First-Line Fixed-Combination Psoriasis Treatment Is Associated With Lower Healthcare Costs. Skinmed. 2016; 14(4):266-272.
    View in: PubMed
    Score: 0.532
  3. Kin KC, Hill D, Feldman SR. Calcipotriene and betamethasone dipropionate for the topical treatment of plaque psoriasis. Expert Rev Clin Pharmacol. 2016 Jun; 9(6):789-97.
    View in: PubMed
    Score: 0.524
  4. Sandoval LF, Huang KE, Harrison J, Clark A, Feldman SR. Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference. Cutis. 2014 Dec; 94(6):304-9.
    View in: PubMed
    Score: 0.474
  5. Feldman SR, Levi E, Pathak P, Kakatkar S, Balkrishnan R. Using a single product (calcipotriene/betamethasone topical suspension) vs multiple products to manage body and scalp psoriasis: comparisons in resource utilization and costs. J Med Econ. 2013 Dec; 16(12):1405-13.
    View in: PubMed
    Score: 0.438
  6. Satyaprakash A, Balkrishnan R, Camacho FT, Jayawant SS, Fleischer AB, Feldman SR. Quality of dermatologic care delivered by physician assistants: an analysis of prescribing behavior for the combination antifungal agent clotrimazole-betamethasone. Arch Dermatol. 2007 Dec; 143(12):1591-2.
    View in: PubMed
    Score: 0.292
  7. Asche CV, Kim M, Feldman SR, Zografos P, Lu M. Budget impact model in moderate-to-severe psoriasis vulgaris assessing effects of calcipotriene and betamethasone dipropionate foam on per-patient standard of care costs. J Med Econ. 2017 Sep; 20(9):1000-1006.
    View in: PubMed
    Score: 0.141
  8. Ahn CS, Awadalla F, Huang KE, Yentzer B, Dabade TS, Feldman SR. Patterns of vitamin D analog use for the treatment of psoriasis. J Drugs Dermatol. 2013 Aug; 12(8):906-10.
    View in: PubMed
    Score: 0.108
  9. Dabade TS, Feldman SR. A consideration when interpreting outpatient data. J Am Acad Dermatol. 2011 Jun; 64(6):1180-1.
    View in: PubMed
    Score: 0.093
  10. Balkrishnan R, Cook JM, Shaffer MP, Saltzberg FB, Feldman SR, Fleischer AB. Analysis of factors associated with prescription of a potentially inappropriate combination dermatological medication among US outpatient physicians. Pharmacoepidemiol Drug Saf. 2004 Mar; 13(3):133-8.
    View in: PubMed
    Score: 0.056
  11. Railan D, Wilson JK, Feldman SR, Fleischer AB. Pediatricians who prescribe clotrimazole-betamethasone diproprionate (Lotrisone) often utilize it in inappropriate settings regardless of their knowledge of the drug's potency. Dermatol Online J. 2002 Oct; 8(2):3.
    View in: PubMed
    Score: 0.051
  12. Wong JW, Davis SA, Feldman SR, Koo JY. Trends in older adult psoriasis outpatient health care practices in the United States. J Drugs Dermatol. 2012 Aug; 11(8):957-62.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.